Long‐term safety and efficacy of 24‐hour levodopa‐carbidopa intestinal gel in Parkinson's disease

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Movement disorders Jg. 34; H. 11; S. 1747 - 1748
Hauptverfasser: Morales‐Briceño, Hugo, Mahant, Neil, Ha, Ainhi D., Chang, Florence C.F., Kim, Samuel D., Griffith, Jane, Tsui, David, Galea, Donna, Fung, Victor S.C.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Hoboken, USA John Wiley & Sons, Inc 01.11.2019
Wiley Subscription Services, Inc
Schlagworte:
Intestine
Levodopa
Movement disorders
Neurodegenerative diseases
Parkinson's disease
ISSN:0885-3185, 1531-8257, 1531-8257
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Bibliographie:Relevant conflicts of interest/financial disclosures
Full financial disclosures and author roles may be found in the online version of this article.
Nursing salaries for J.G. and D.G. are part funded by unrestricted grants to the Western Sydney Local Health District from AbbVie. V.F. has been on paid Advisory Boards for AbbVie. J.G. has received travel grants and speaking honoraria from AbbVie.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Correspondence-1
ISSN:0885-3185
1531-8257
1531-8257
DOI:10.1002/mds.27883